- Strong cost and market leadership in specific API’s
- Diversified manufacturing capabilities in different types of API’s (SSP’s, carbapenams, Cephalosporin’s, synthetic products etc).
- Our API facilities are approved by USFDA, EDQM, WHO.
- API technology development and manufacturing capabilities.
- Strong R&D base for new molecules development activities.
- State of art API facilities with latest technological capabilities for execution.
- Strong quality compliance systems to ensure consistent supply of quality API’s
- Capabilities of sterile API manufacturing.